Get the Stockscreener App
1.66
4.40%
0.07
Sellas Life Sciences Group Inc stock is traded at $1.66, with a volume of 1.80M.
It is up +4.40% in the last 24 hours and down -20.19% over the past month.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
See More
Previous Close:
$1.59
Open:
$1.59
24h Volume:
1.80M
Relative Volume:
0.61
Market Cap:
$165.63M
Revenue:
-
Net Income/Loss:
$-37.34M
P/E Ratio:
-1.2206
EPS:
-1.36
Net Cash Flow:
$-36.91M
1W Performance:
-7.78%
1M Performance:
-20.19%
6M Performance:
+2.47%
1Y Performance:
+34.41%
1-Day Range:
$1.562
$1.71
1-Week Range:
$1.562
$1.82
52-Week Range:
$0.772
$2.2691
Sellas Life Sciences Group Inc Stock (SLS) Company Profile
Name
Sellas Life Sciences Group Inc
Sector
Industry
Phone
(646) 200-5278
Address
7 TIMES SQUARE, NEW YORK, NY
Compare SLS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SLS
Sellas Life Sciences Group Inc
|
1.66 | 158.65M | 0 | -37.34M | -36.91M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Sellas Life Sciences Group Inc Stock (SLS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-21-21 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-01-18 | Initiated | Oppenheimer | Outperform |
| Apr-02-18 | Initiated | H.C. Wainwright | Buy |
| Mar-19-18 | Upgrade | Maxim Group | Hold → Buy |
Sellas Life Sciences Group Inc Stock (SLS) Latest News
How does SELLAS Life Sciences Group Inc. compare to its industry peersSwing Trade Forecasts For Smart Trading - jammulinksnews.com
What is the dividend policy of SELLAS Life Sciences Group Inc. stockRetirement Planning Watchlist For Every Investor - jammulinksnews.com
What catalysts could drive SELLAS Life Sciences Group Inc. stock higher in 2025Wealth Building Trend Scanner For Smart Trading - jammulinksnews.com
SELLAS Life Sciences Group (SLS) Upgraded to Buy: What Does It Mean for the Stock? (Revised) - Yahoo Finance
Published on: 2025-07-29 08:30:26 - metal.it
What risks could impact SELLAS Life Sciences Group Inc. stock performanceIntraday Trend Analysis for Fast Gains Released - beatles.ru
Should I hold or sell SELLAS Life Sciences Group Inc. stock in 2025Market Forecast Updates That Work - jammulinksnews.com
Does SELLAS Life Sciences Group Inc. stock perform well during market downturnsFinancial News Target Finder That Work - jammulinksnews.com
What are analysts’ price targets for SELLAS Life Sciences Group Inc. in the next 12 monthsBest Dividend Updates From AI Tools - jammulinksnews.com
How strong is SELLAS Life Sciences Group Inc. company’s balance sheetFree Technical Analysis Support - jammulinksnews.com
How Resilient Is SELLAS Life Sciences Group Inc. Stock During Economic DownturnsTop Performer Shortlist - metal.it
What analysts say about SELLAS Life Sciences Group Inc. stockExplosive portfolio gains - Autocar Professional
SELLAS Life Sciences Group Inc. Stock Analysis and ForecastTriple-digit profit margins - PrintWeekIndia
What institutions are buying SELLAS Life Sciences Group Inc. stock nowStrong return on assets - jammulinksnews.com
What drives SELLAS Life Sciences Group Inc. stock priceUnprecedented growth rates - PrintWeekIndia
Is SELLAS Life Sciences Group Inc. a good long term investmentExceptional profit potential - PrintWeekIndia
What drives USEA stock priceMassive wealth growth - jammulinksnews.com
What makes SELLAS Life Sciences Group Inc. stock attractive to long term investorsMomentum Swing Watchlist - beatles.ru
SELLAS Life Sciences Group (NASDAQ:SLS) Stock Price Expected to Rise, Maxim Group Analyst Says - Defense World
Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities - Finansavisen
Sellas Life Sciences Group Inc Stock (SLS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):